Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06125860

BEP Targeting Strategies in Ethiopia

Targeting Strategies of Antenatal Balanced Energy and Protein Supplementation in Addis Ababa, Ethiopia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
6,750 (estimated)
Sponsor
Harvard School of Public Health (HSPH) · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized effectiveness study is to evaluate the different targeting strategies for the delivery of balanced energy and protein (BEP) supplements among pregnant women in Addis Ababa, Ethiopia. The main goals of the study are to: 1) determine the effectiveness of two individual-based antenatal BEP targeting strategies for preventing adverse pregnancy outcomes; 2) compare the cost-effectiveness of the universal BEP provision with two individual-based targeting strategies for preventing adverse pregnancy outcomes; and 3) generate implementation evidence regarding the feasibility and acceptability of different antenatal BEP targeting strategies. Pregnant women will be enrolled during pregnancy, assigned to different strategies of BEP supplementation, and followed from pregnancy through six weeks postpartum to evaluate the impacts of different BEP targeting strategies on pregnancy, maternal, and child outcomes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTargeted BEP based on baseline nutritional statusIn Arm 2 (targeted BEP based on baseline nutritional status), in addition to the standard of care, participants will receive BEP supplements if their baseline BMI is less than 18.5 or their baseline mid-upper arm circumference is less than 23 cm.
DIETARY_SUPPLEMENTTargeted BEP based on baseline nutritional status and monthly GWG monitoringIn Arm 3 (targeted BEP based on baseline nutritional status and monthly GWG monitoring), in addition to the standard of care, participants will receive BEP supplements if their baseline BMI is less than 18.5 or their baseline mid-upper arm circumference is less than 23 cm; participants with an inadequate GWG at a monthly follow-up visit will receive additional BEP supplements.
DIETARY_SUPPLEMENTUniversal BEPIn Arm 4 (universal BEP), all participants will receive BEP supplements from baseline through the end of pregnancy.

Timeline

Start date
2023-08-07
Primary completion
2026-07-31
Completion
2026-07-31
First posted
2023-11-09
Last updated
2025-12-19

Locations

1 site across 1 country: Ethiopia

Source: ClinicalTrials.gov record NCT06125860. Inclusion in this directory is not an endorsement.